- Live market news
- Stocks
- IBRX
Immunitybio Inc
IBRXStockUSA
8.01USD−0.92 (−10.30%)Live · 5 Nov, 20:59 UTC
About
Immunitybio Inc
The ImmunityBio COVID-19 vaccine, codenamed hAd5, is a non replicating viral vector COVID-19 vaccine developed by the United States-based pharmaceutical company ImmunityBio.
Key figures
- Previous close
- 8.93
- Open
- 8.78
- Day range
- 8.00 – 8.79
- 52-week range
- —
- Volume
- 12.5M
Latest news on IBRXranked by Oyticker for market impact
In detailthe same figures as in Oyticker Charts
Performance
1D−10.3%
Ranges & volume
Day8.00 – 8.79
52 weeks—
- Open
- 8.78
- Prev. close
- 8.93
Volume 12.5Mavg —
Risk · 1 year
Not enough historyRisk needs at least a month of daily sessions.
Seasonality
Not enough historySeasonality needs several months of data.
SEC filings
All its filingsWhat IBRX filed
- 9 Nov 2026
- 9 Nov 2026
- 9 Nov 2026
- 14 Oct 2026
- 4 Aug 2026
- 4 Aug 2026
- 30 Jul 2026
- 10 Jun 2026
- 18 May 2026
Investor communication
From SEC EDGAR, the public record of what US-listed companies file. Each document opens on sec.gov.
Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.